Cytochrome P450 2B6 (human) Yeast Reductase
Stability : 2 years
Mechanism-based inhibition of CYP2B6 in human liver microsomes by thienopyridine antiplatelet agents ticlopidine and clopidogrel and the thiolactone metabolites of those two agents plus that of prasugrel were investigated by determining the time- and concentration-dependent inhibition of the activity of bupropion hydroxylase as the typical CYP2B6 activity. CYP2B6 represents approximately 6% of the hepatic cytochrome P450 pool and demonstrates more than 100-fold interindividual variability in the activity. In addition, genetic polymorphism in CYP2B6 was shown to result in decreased enzyme activity.
Storage : -80°C
Send enquiry online
After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: email@example.com
2. Tel: +86 592 5365887
3. WhatsApp: +86 189 6515 7632
4. Send enquiry online: